Isolation and identification of fungal species in patients of recalcitrant tinea corporis and/or tinea cruris attending tertiary care hospital in Karachi
DOI:
https://doi.org/10.66344/jpad.33.3.2023.2227Keywords:
Dermatophytes, ; Antifungals, Recalcitrant casesAbstract
Abstract Background: Tinea corporis and Tinea cruris is one of the chief infection seen in dermatology clinics affecting every age and gender. The rapidly rising prevalence of superficial fungal infection in our population warrants mycological analysis to establish any change in the causative dermatophytic specie responsible for ticking up the number of the cases. Objective: To isolate and identify the fungal species in patients of recalcitrant tinea corporis and / or tinea cruris attending tertiary care hospital in Karachi. Methods: This Cross-sectional study was conducted in the Outpatient Department of Dermatology, Dow University Hospital, Karachi, Pakistan from 11th April 2022 till 10th October 2022. It comprised of 60 patients who had either received one complete course of oral antifungal treatment and had responded poorly to the therapy (identified on the basis of clinical response) and had a recurrence of disease after cure. The skin scrappings were collected from these patients and then microscopy and cultures were performed. Results: Out was 60 patients of Recalcitrant Tinea Corporis and /or T .cruris KOH mount was positive in 43 (71.6%) patients and the culture isolated and identified the causative species in 53 (88.3%) patients. T.Tonsurans account for about 33.3% of the cases followed by T. Mentagrophytes accounting for 15% of the patients. In 11.6 % of the patients isolated specie was T. Rubrum. Conclusion: Rise in the number of recalcitrant dermatophytosis could possibly due to change in the species causing dermatophytosis. Mycological analysis can help in identifying such species and facilitate in the treatment of these patients. Keywords: Dermatophytes, Antifungals, Recalcitrant cases.References
Zhan P, Liu W. The Changing Face of Dermatophytic Infections Worldwide. Mycopathologia. 2017;182(1-2):77-86.
doi:10.1007/s11046-016-0082-8
Sardana K, Kaur R, Arora P, Goyal R, Ghunawat S. Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?. Indian Dermatol Online J. 2018;9(2):90-95. doi:10.4103/idoj.IDOJ_137_17
Ameen M. Epidemiology of superficial fungal infections. Clin Dermatol. 2010;28(2):197-201. doi:10.1016/j.clindermatol.2009.12.005
Majid I, Sheikh G, Kanth F, Hakak R. Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study. Indian J Dermatol. 2016;61(5):529-533.
doi:10.4103/0019-5154.190120
World Health Organization. Epidemiology and management of common skin diseases in children in developing countries. World Health Organization; 2005.
Degreef H. Clinical forms of dermatophytosis (ringworm infection). Mycopathologia. 2008;166(5-6):257-65. doi:10.1007/s11046-008-9101-8
Majid I, Sheikh G, Kanth F, Hakak R. Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study. Indian J Dermatol. 2016;61(5):529-33.
doi:10.4103/0019-5154.190120
Uthansingh K, Sahu MK, Debata NK, Behera D, Panda K, Sahu MC. Isolation and identification of fungus associated with skin and nail scalps of patients in a tertiary care teaching hospital. Apollo Medicine. 2019;16(1):16.
Wu SX, Guo NR, Li XF, et al. Human pathogenic fungi in China--emerging trends from ongoing national survey for 1986, 1996, and 2006. Mycopathologia. 2011;171(6):387-93.
doi:10.1007/s11046-011-9398-6
Griffiths CE, Barker JN. Fungal Infection. Hay RJ, Ashbee.HR, Rook’s textbook of dermatology. Oxford:Wiley Black well ;2016 . p. 32.36-32.37.
Kovitwanichkanont T, Chong AH. Superficial fungal infections. Aust J Gen Pract. 2019;48(10):706-711.
doi:10.31128/AJGP-05-19-4930
Balakumar S, Rajan S, Thirunalasundari T, Jeeva S. Epidemiology of dermatophytosis in and around Tiruchirapalli, Tamilnadu, India. Asian Pac J Trop Dis. 2012;2(4):286-9.
Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide [published correction appears in Mycoses. 2009 Jan;52(1):95]. Mycoses. 2008;51 Suppl 4:2-15.
doi:10.1111/j.1439-0507.2008.01606.x
Theel ES, Hall L, Mandrekar J, Wengenack NL. Dermatophyte identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2011;49(12):4067-71.
doi:10.1128/JCM.01280-11
Mohammad. J, Seema. I. Fungal media and culture.In: Zafar A, Jabeen K, Farooqi J. Practical guide and atlas for the diagnosis of fungal infections. AKU. 2017:10-9.
Bishnoi A, Vinay K, Dogra S. Emergence of recalcitrant dermatophytosis in India. Lancet Infect Dis. 2018;18(3):250-1.
doi:10.1016/S1473-3099(18)30079-3
Kaur I, Chaudhary A, Singh H. Clinico-microbiological aspects of tinea corporis in North India: Emergence of Trichophyton tonsurans. Int J Res Dermatol. 2019;5:144-9.
Pierre Y, Christopher S, Namoomba SH, Lukwesa M, Kwenda G. Isolation and Identification of fungi from suspected fungal skin infections in patients attending the Dermatology Clinic at University Teaching Hospital. IOSR J Pharm. 2016;10:55-61.
Ambwani JK, Kumbher BA, Kumar M, Shaikh AW, Shaikh MA, Shaikh AB. Frequency of Dermatophytosis in Karachi. Pak J Med Health Sci. 2016;10(4):1169-70.
Kaur R, Panda PS, Sardana K, Khan S. Mycological Pattern of Dermatomycoses in a Tertiary Care Hospital. J Trop Med. 2015;2015:157828. doi:10.1155/2015/157828
Dabas Y, Xess I, Singh G, Pandey M, Meena S. Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines. J Fungi (Basel). 2017;3(2):17. Published 2017 Mar 23. doi:10.3390/jof3020017.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.